Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.200
+0.100 (3.23%)
At close: Oct 8, 2025, 4:00 PM EDT
3.209
+0.009 (0.29%)
After-hours: Oct 8, 2025, 7:57 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $24.02 million as of October 8, 2025. Its market cap has increased by 72.00% in one year.
Market Cap
24.02M
Enterprise Value
30.89M
1-Year Change
72.00%
Ranking
Category
Stock Price
$3.20
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $24.02M, a decrease of -76.80%. That is a compound annual growth rate of -26.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 24.02M | -4.95% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
| Dec 11, 2020 | 103.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |